By Erika Wu, Business Development Manager, Global Tech Hubs, LSN
The National Institute of Health (NIH) is working with Life Science Nation‘s RESI conference during JPM Healthcare Week 2024 to feature 10 startups in the Innovator’s Pitch Challenge (IPC). This long-term partnership between the NIH and LSN expands broader than the RESI conferences. In September 2022, NIH’s National Institute on Aging (NIA) invited 40+ life science entrepreneurs from their Healthy Aging Start-Up Challenge to participate in LSN’s entrepreneurial educational across two digital and two in-person sessions. These entrepreneurs were taught how to manage their global investor target lists and fundraising campaigns and engaged in interactive sessions to practice their tagline and elevator pitches. These entrepreneurs continued to attend RESI throughout 2022 and 2023 to meet with other CEOs, investors, and strategic partners, and a new cohort from NIH will be participating in the Innovator’s Pitch Challenge (IPC) at RESI JPM 2024. The excitement to partner again and deepen community involvement reflects a growing awareness of the transformative power that collaboration can have on startups in the early-stage life science arena.
From the National Institute of Health: NIH Is the largest funder of life science research and development in the world. In 2023, America’s SEED fund (the Small Business Programs) at NIH supported the development of nearly 1,400 products with over $1.3 billion of non-dilutive funding and a strong suite of commercialization assistance programming. NIH’s portfolio includes all technology types, from research tools to diagnostics to therapeutic solutions, addressing all aspects of human health.
At RESI JPM in San Francisco, 10 of the most innovative small businesses from the NIH portfolio will highlight their life science solutions, from at-home or remote diagnostic and monitoring solutions to improving the function of our most basic organ systems and organelles. Each of these companies has received direct mentoring from an NIH Entrepreneur in Residence, and several have received regulatory or reimbursement consultations from NIH’s SEED (Small business Education and Entrepreneurial Development) office.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Next Phase Newsletter 
Leave a comment